Trial Outcomes & Findings for Hepatitis C Virus (HCV) Treatment Completion or Withdrawal (NCT NCT00674492)
NCT ID: NCT00674492
Last Updated: 2015-05-15
Results Overview
Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.
COMPLETED
21 participants
Zero to five years since ending treatment.
2015-05-15
Participant Flow
Participant milestones
| Measure |
Group 1
patients who initiated antiviral treatment for hepatitis C
|
|---|---|
|
Overall Study
STARTED
|
21
|
|
Overall Study
COMPLETED
|
21
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
Baseline characteristics by cohort
| Measure |
Group 1
n=21 Participants
patients who initiated antiviral treatment for hepatitis C
|
|---|---|
|
Age, Continuous
|
57 years
n=99 Participants
|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
20 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
1 Participants
n=99 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
20 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
21 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: Zero to five years since ending treatment.Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.
Outcome measures
| Measure |
Group 1
n=21 Participants
patients who initiated antiviral treatment for hepatitis C
|
|---|---|
|
Attributes of Treatment Experience
Avoid Bad End
|
14 participants
|
|
Attributes of Treatment Experience
Perseverence
|
15 participants
|
|
Attributes of Treatment Experience
Achieve Cure
|
7 participants
|
|
Attributes of Treatment Experience
Redemption
|
9 participants
|
Adverse Events
Group 1
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Jack A. Clark, PhD
Center for Healthcare Organization and Implementation Research
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place